Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

NCT07668856 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT07668856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Recruiting
Start date
February 6, 2025
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, refractory epilepsy, refractory epilepsy in children